Moderna does trade at a ludicrous valuation. The PE ratio for this company is 14.55. Considering their growth in the last year (from being not profitable to a profit of $17/share in the past three quarters) they should be trading at a PE of at least 100. With the worldwide need for continued vaccination, the growth of Moderna will continue for years.
News 
Market Data 
Discover 
